Bristol Myers petitions the Supreme Court in a final bid to prove Gilead's Kite infringed on CAR-T patents
Five years after Juno and Sloan Kettering launched a bitterly fought legal campaign against Gilead’s Kite Pharma, claiming the biotech rival had infringed on its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.